several < severe < severely

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 83.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000021 (2010)	Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]	Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000030 (2010)	Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]	A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000044 (2010)	Yoh Arita [Japon] ; Yasushi Sakata [Japon] ; Takao Sudo [Japon] ; Tetsuo Maeda [Japon] ; Ken Matsuoka [Japon] ; Keito Tamai [Japon] ; Kaori Higuchi [Japon] ; Wataru Shioyama [Japon] ; Yoshikazu Nakaoka [Japon] ; Yuzuru Kanakura [Japon] ; Keiko Yamauchi-Takihara [Japon]	The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000050 (2011)	Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada	Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000056 (2015)	Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne]	Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab
000058 (2014)	Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel	Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000071 (2010)	A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]	Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000096 (2009)	Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]	Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000130 (2007)	Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]	Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000151 (2012)	I. Kötter [Allemagne]	Update Morbus Behçet
000161 (2013)	I. Kötter [Allemagne] ; J. C. Henes [Allemagne]	Etablierte Medikamente
000176 (2010)	I. H. Tarner [Allemagne] ; U. Müller-Ladner [Allemagne] ; C. Hamm [Allemagne]	Biologika und kardiovaskuläres Risiko
000206 (2012)	K. Krüger [Allemagne] ; J. Sieper [Allemagne]	Off-Label-Therapie bei rheumatoider Arthritis und Spondyloarthritiden
000245 (2012)	M. Frosch [Allemagne] ; D. Holzinger [Allemagne] ; J. Roth [Allemagne]	Systemische Verlaufsform der juvenilen idiopathischen Arthritis
000279 (2010)	Arnd Heiligenhaus [Allemagne] ; Stephan Thurau [Allemagne] ; Maren Hennig [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Gerhild Wildner [Allemagne]	Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease
000315 (2011)	Kjell Tullus [Royaume-Uni]	New developments in the treatment of systemic lupus erythematosus

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "severe" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "severe" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    severe
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021